Literature DB >> 19261615

Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene.

Yan Zhong1, Harvey J Armbrecht, Sylvia Christakos.   

Abstract

Although parathyroid hormone (PTH) induces 25-hydroxyvitamin D(3) (25(OH)D(3)) 1alpha-hydroxylase (1alpha(OH)ase) under hypocalcemic conditions, previous studies showed that calcitonin, not PTH, has an important role in the maintenance of serum 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) under normocalcemic conditions. In this study we report that 1alpha(OH)ase transcription is strongly induced by calcitonin in kidney cells and indicate mechanisms that underlie this regulation. The transcription factor C/EBPbeta is up-regulated by calcitonin in kidney cells and results in a significant enhancement of calcitonin induction of 1alpha(OH)ase transcription and protein expression. Mutation constructs of the 1alpha(OH)ase promoter demonstrate the importance of the C/EBPbeta binding site at -79/-73 for activation of the 1alpha(OH)ase promoter by calcitonin. The SWI/SNF chromatin remodeling complex was found to cooperate with calcitonin in the regulation of 1alpha(OH)ase. Chromatin immunoprecipitation analysis showed that calcitonin recruits C/EBPbeta to the 1alpha(OH)ase promoter, and Re-chromatin immunoprecipitation analysis (sequential chromatin immunoprecipitations using different antibodies) showed that C/EBPbeta and BRG1, an ATPase that is a component of the SWI/SNF complex, bind simultaneously to the 1alpha(OH)ase promoter. These findings are the first to address the dynamics between calcitonin, C/EBPbeta, and SWI/SNF in the regulation of 1alpha(OH)ase and provide a mechanism, for the first time, for calcitonin induction of 1alpha(OH)ase. Because plasma calcitonin as well as 1,25(OH)(2)D(3) have been reported to be increased during pregnancy and lactation and in early development, these findings suggest a mechanism that may account, at least in part, for the increase in plasma 1,25(OH)(2)D(3) during these times of increased calcium requirement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261615      PMCID: PMC2670111          DOI: 10.1074/jbc.M806561200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter.

Authors:  H L Brenza; C Kimmel-Jehan; F Jehan; T Shinki; S Wakino; H Anazawa; T Suda; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

2.  Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.

Authors:  S Kitanaka; K Takeyama; A Murayama; T Sato; K Okumura; M Nogami; Y Hasegawa; H Niimi; J Yanagisawa; T Tanaka; S Kato
Journal:  N Engl J Med       Date:  1998-03-05       Impact factor: 91.245

3.  Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats.

Authors:  T Shinki; Y Ueno; H F DeLuca; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase gene.

Authors:  X F Kong; X H Zhu; Y L Pei; D M Jackson; M F Holick
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

5.  Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.

Authors:  Tracy Xiao Cui; Graciela Piwien-Pilipuk; Jeffrey S Huo; Julianne Kaplani; Roland Kwok; Jessica Schwartz
Journal:  Mol Endocrinol       Date:  2005-04-28

6.  Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching.

Authors:  Akiko Murayama; Mi-sun Kim; Junn Yanagisawa; Ken-ichi Takeyama; Shigeaki Kato
Journal:  EMBO J       Date:  2004-04-07       Impact factor: 11.598

7.  The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin.

Authors:  Qi Shen; Sylvia Christakos
Journal:  J Biol Chem       Date:  2005-09-29       Impact factor: 5.157

8.  Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.

Authors:  Nicolas Di-Poï; Béatrice Desvergne; Liliane Michalik; Walter Wahli
Journal:  J Biol Chem       Date:  2005-09-15       Impact factor: 5.157

9.  Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.

Authors:  Puneet Dhawan; Xiaorong Peng; Amelia L M Sutton; Paul N MacDonald; Colleen M Croniger; Christian Trautwein; Michael Centrella; Thomas L McCarthy; Sylvia Christakos
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

10.  The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3.

Authors:  A Murayama; K Takeyama; S Kitanaka; Y Kodera; T Hosoya; S Kato
Journal:  Biochem Biophys Res Commun       Date:  1998-08-10       Impact factor: 3.575

View more
  21 in total

1.  Brg1 Controls the Expression of Pax7 to Promote Viability and Proliferation of Mouse Primary Myoblasts.

Authors:  Teresita Padilla-Benavides; Brian T Nasipak; Anthony N Imbalzano
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

Review 2.  Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase.

Authors:  J S Adams; M Hewison
Journal:  Arch Biochem Biophys       Date:  2012-03-14       Impact factor: 4.013

3.  Mechanisms involved in vitamin D mediated intestinal calcium absorption and in non-classical actions of vitamin D.

Authors:  Sylvia Christakos; Puneet Dhawan; Dare Ajibade; Bryan S Benn; Jingjing Feng; Sneha S Joshi
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-07       Impact factor: 4.292

4.  Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness.

Authors:  Bruce W Hollis; Donna Johnson; Thomas C Hulsey; Myla Ebeling; Carol L Wagner
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

5.  A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3.

Authors:  Mark B Meyer; Paul D Goetsch; J Wesley Pike
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

6.  The vitamin d receptor in thyroid development and function.

Authors:  Isabelle Clinckspoor; Anne-Catherine Gérard; Jacqueline Van Sande; Marie-Christine Many; Lieve Verlinden; Roger Bouillon; Geert Carmeliet; Chantal Mathieu; Annemieke Verstuyf; Brigitte Decallonne
Journal:  Eur Thyroid J       Date:  2012-09-22

7.  Vitamin D for health: a global perspective.

Authors:  Arash Hossein-nezhad; Michael F Holick
Journal:  Mayo Clin Proc       Date:  2013-06-18       Impact factor: 7.616

Review 8.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 9.  The role of vitamin D in pregnancy and lactation: emerging concepts.

Authors:  Carol L Wagner; Sarah N Taylor; Donna D Johnson; Bruce W Hollis
Journal:  Womens Health (Lond)       Date:  2012-05

10.  Vitamin D metabolism and action in human bone marrow stromal cells.

Authors:  Shuanhu Zhou; Meryl S LeBoff; Julie Glowacki
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.